GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chaoju Eye Care Holdings Ltd (HKSE:02219) » Definitions » Beneish M-Score

Chaoju Eye Care Holdings (HKSE:02219) Beneish M-Score : -2.31 (As of Mar. 24, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Chaoju Eye Care Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.31 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Chaoju Eye Care Holdings's Beneish M-Score or its related term are showing as below:

HKSE:02219' s Beneish M-Score Range Over the Past 10 Years
Min: -3.26   Med: -2.52   Max: -2.12
Current: -2.31

During the past 6 years, the highest Beneish M-Score of Chaoju Eye Care Holdings was -2.12. The lowest was -3.26. And the median was -2.52.


Chaoju Eye Care Holdings Beneish M-Score Historical Data

The historical data trend for Chaoju Eye Care Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chaoju Eye Care Holdings Beneish M-Score Chart

Chaoju Eye Care Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -3.26 -2.72 -2.12 -2.31

Chaoju Eye Care Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -2.12 - -2.31 -

Competitive Comparison of Chaoju Eye Care Holdings's Beneish M-Score

For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chaoju Eye Care Holdings's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Chaoju Eye Care Holdings's Beneish M-Score falls into.



Chaoju Eye Care Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Chaoju Eye Care Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8639+0.528 * 0.9681+0.404 * 1.7779+0.892 * 1.3549+0.115 * 0.8323
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.06+4.679 * -0.04915-0.327 * 1.1883
=-2.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$61 Mil.
Revenue was HK$1,498 Mil.
Gross Profit was HK$679 Mil.
Total Current Assets was HK$1,892 Mil.
Total Assets was HK$3,197 Mil.
Property, Plant and Equipment(Net PPE) was HK$648 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$135 Mil.
Selling, General, & Admin. Expense(SGA) was HK$358 Mil.
Total Current Liabilities was HK$375 Mil.
Long-Term Debt & Capital Lease Obligation was HK$166 Mil.
Net Income was HK$250 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$408 Mil.
Total Receivables was HK$52 Mil.
Revenue was HK$1,106 Mil.
Gross Profit was HK$485 Mil.
Total Current Assets was HK$2,027 Mil.
Total Assets was HK$3,041 Mil.
Property, Plant and Equipment(Net PPE) was HK$662 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$111 Mil.
Selling, General, & Admin. Expense(SGA) was HK$249 Mil.
Total Current Liabilities was HK$274 Mil.
Long-Term Debt & Capital Lease Obligation was HK$159 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(60.969 / 1497.936) / (52.089 / 1105.597)
=0.040702 / 0.047114
=0.8639

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(485.433 / 1105.597) / (679.383 / 1497.936)
=0.439069 / 0.453546
=0.9681

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1891.871 + 647.621) / 3196.903) / (1 - (2026.979 + 662.271) / 3040.982)
=0.20564 / 0.115664
=1.7779

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1497.936 / 1105.597
=1.3549

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(110.963 / (110.963 + 662.271)) / (134.93 / (134.93 + 647.621))
=0.143505 / 0.172423
=0.8323

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(358.156 / 1497.936) / (249.388 / 1105.597)
=0.2391 / 0.225569
=1.06

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((166.06 + 374.881) / 3196.903) / ((159.45 + 273.576) / 3040.982)
=0.169208 / 0.142397
=1.1883

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(250.381 - 0 - 407.508) / 3196.903
=-0.04915

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Chaoju Eye Care Holdings has a M-score of -2.31 suggests that the company is unlikely to be a manipulator.


Chaoju Eye Care Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Chaoju Eye Care Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Chaoju Eye Care Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 14 Yard, West 3rd Ring South Road, Block A, Shouke Building, 24th Floor, East Zone, Fengtai District, Beijing, CHN
Chaoju Eye Care Holdings Ltd is a ophthalmic medical service group in North China engaged in engaged in the provision of in-patient services, out-patient services and sales of optical products. The company generate revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control and provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases.
Executives
Zhang Junfeng 2103 Interests held jointly with another person
Zhang Xiaoli 2103 Interests held jointly with another person
Zhang Bozhou 2103 Interests held jointly with another person
Areo Holdings Limited 2201 Interest of corporation controlled by you
Li Gabriel 2201 Interest of corporation controlled by you
Lam Lai Ming 2201 Interest of corporation controlled by you
Orchid Asia Vii, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Gp, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group Management, Limited 2201 Interest of corporation controlled by you
Oavii Holdings, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Global Investment Limited 2101 Beneficial owner
Wang Stephen Hui 2201 Interest of corporation controlled by you
Xia Men Chao Xi Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Zhang Wenwen 2201 Interest of corporation controlled by you

Chaoju Eye Care Holdings Headlines

No Headlines